Prevalence of Myocardial Scars on CMR After COVID-19 Infection
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 231 participants.
Also called NCT04636320
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 231 participants
- Registry
-
NCT04636320
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France
- Registry status
- Completed
Technical summary
Registry record NCT04636320. Non-randomized; no masking; primary purpose diagnostic. Start 2020-06-13 (actual); primary completion 2022-04-04 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Prevalence of Myocardial Scars on CMR After COVID-19 Infection
- Acronym
- COVID-CMR
- Condition
- COVID-19
- Condition
- Virus Disease
- Intervention (Device)
- Contrast-enhanced CMR
- Intervention (Diagnostic test)
- Exercise test ECG (electrocardiogram)
- Intervention (Biological)
- Blood sample
- Intervention (Diagnostic test)
- Resting 12 lead ECG
- Intervention (Diagnostic test)
- 24 hour Holter ECG
- Lead sponsor
- University Hospital, Bordeaux
- Collaborator
- Grant Agreement ERC n°715093
- Collaborator
- University of Bordeaux
Record details
- Record id
cardio:ct-nct04636320- Content hash
c2d276d8a5d99436b5c7b1d8d2233ac7724d6d62f248781e05771f5db46394d3